Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Interest Coverage Ratio (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Interest Coverage Ratio for 7 consecutive years, with 11.99 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio fell 14.21% to 11.99 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.07 through Dec 2025, up 22.14% year-over-year, with the annual reading at 9.86 for FY2025, 51.25% down from the prior year.
  • Interest Coverage Ratio hit 11.99 in Q4 2025 for BridgeBio Pharma, up from 12.37 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.01 in Q1 2024 to a low of 17.2 in Q1 2021.
  • Historically, Interest Coverage Ratio has averaged 8.13 across 5 years, with a median of 8.04 in 2023.
  • Biggest five-year swings in Interest Coverage Ratio: soared 100.23% in 2024 and later crashed 17047.93% in 2025.
  • Year by year, Interest Coverage Ratio stood at 10.94 in 2021, then surged by 40.92% to 6.46 in 2022, then tumbled by 35.4% to 8.75 in 2023, then decreased by 19.98% to 10.5 in 2024, then dropped by 14.21% to 11.99 in 2025.
  • Business Quant data shows Interest Coverage Ratio for BBIO at 11.99 in Q4 2025, 12.37 in Q3 2025, and 3.57 in Q2 2025.